Joshua Blodgett earned his PhD at the University of Illinois Urbana-Champaign, working on bacterial phosphonate antibiotic biosynthesis with William Metcalf. He completed his postdoctoral work at Harvard Medical School with Jon Clardy, examining the chemical ecology of insect-microbial symbioses. Recruited by Third Rock Ventures, he joined the founding scientific team of WarpDrive Bio, a genomes-to-drugs biotech in Cambridge, MA, to lead the Microbiology group. He returned to academia in late 2014 as a Biology faculty member at Washington University in St Louis. His lab focuses on the genetics, regulation, and metabolism of bioactive molecules in actinomycete bacteria.